HealthDyne Executives Advocate Direct-to-Patient Drug Sales at Asembia AXS26
Loading article…
Related News
- HealthDyne Eyes Major Growth in Direct-to-Employer Market
- HealthDyne Eyes Major Growth in Direct-to-Employer Market, Targeting 1 Million Lives
- IRA Price Negotiation Concerns at Asembia AXS26 Summit: Rebates as a Solution
- Specialty Pharmacies Enhance Care Management for Value-Based Care
- Specialty Pharmacy Coaching Lowers Costs, Improves Diabetes Outcomes